4.6 Article

Initial Experience of 10 Imaging Vendors with the IHE SHARAZONE: a New Multivendor Peer-to-Peer Test Service for DICOM Objects

Journal

JOURNAL OF DIGITAL IMAGING
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s10278-023-00881-2

Keywords

DICOM (Digital Imaging and Communications in Medicine); Interoperability; IHE (Integrating the Healthcare Enterprise); SHARAZONE; Medical imaging; Cross-vendor exchange

Ask authors/readers for more resources

Alignment of DICOM capabilities among vendors is crucial for improving interoperability in the healthcare industry. To address the lack of a sustainable model for sharing DICOM samples, IHE has introduced the IHE SHARAZONE, a continuous cross-vendor DICOM data sharing test service.
Alignment of DICOM (Digital Imaging and Communications in Medicine) capabilities among vendors is crucial to improve interoperability in the healthcare industry and advance medical imaging (2). However, a sustainable model for sharing DICOM samples is not available. To address this issue, Integrating the Healthcare Enterprise (IHE) has introduced the IHE SHARAZONE, a continuous cross-vendor DICOM data sharing test service. IHE is a highly regarded organization known for profiling standards such as DICOM, HL7 v2 (Health Level Seven, version 2), HL7 CDA (Clinical Document Architecture), and HL7 FHIR (Fast Healthcare Interoperability Resources) into practical solutions for clinical practice. The primary goal of the IHE SHARAZONE is to provide a reliable and consistent cross-vendor DICOM data sharing system. To evaluate its effectiveness, a 5-month pilot was conducted with ten imaging vendors. The pilot concluded with a participant survey, which yielded valuable insights into the initial experience with the IHE SHARAZONE. These findings can inform future improvements and developments to this important service.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available